Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Me-344 | 1374524-68-1 | 98.1% | 348.39 g/mol | C22H20O4 | 5 MG
SDP

Catalog No. 5000264325
Encompass_Preferred

ME-344 is a small-molecule mitochondrial heme oxygenase-1 (HO-1) inhibitor provided for research use only. The compound is supplied with characterization data and safety documentation for laboratory applications, and has a reported molecular formula of C22H20O4 and molecular weight of 348.39 g/mol.

  • Inhibits heme oxygenase-1 (HO-1) activity in mitochondria
  • High purity suitable for research applications
  • Characterized molecular formula and molecular weight
  • Provided with product datasheet and safety data sheet
  • Available in small research-scale quantities
  • For in vitro research use only; not for human or clinical use

Catalog No. 50-002-64325 Supplier Medchemexpress LLC Supplier No. HY1127495MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ME-344 is a small-molecule mitochondrial heme oxygenase-1 (HO-1) inhibitor provided for research use only. The compound is supplied with characterization data and safety documentation for laboratory applications, and has a reported molecular formula of C22H20O4 and molecular weight of 348.39 g/mol.

  • Inhibits heme oxygenase-1 (HO-1) activity in mitochondria
  • High purity suitable for research applications
  • Characterized molecular formula and molecular weight
  • Provided with product datasheet and safety data sheet
  • Available in small research-scale quantities
  • For in vitro research use only; not for human or clinical use

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.